Pfizer Canada issued an update today regarding the availability of EpiPens® in Canada.
Press Release from Pfizer Canada:
Pfizer Canada Inc. and Health Canada are committed to the health and safety of Canadian patients. Pfizer Canada Inc. has secured sufficient quantities of EpiPen® auto-injectors to replace all remaining Allerject® (epinephrine injection, USP) devices affected by Sanofi Canada’s recent nationwide recall.
Now that full EpiPen® and EpiPen® Jr stock is available in Canada, consumers should proceed to contact their pharmacies to replace all remaining unexpired Allerject® devices in their possession. More information on the recall can be found here: http://www.allerject.ca.
To view the full press release, please click here.
–Food Allergy Canada